Physiological testing can help identify patients with obstructive sleep apnoea who are at the highest risk of respiratory depression when using opioid analgesics, Associate Professor David Wang from the Woolcock Institute has told ATS delegates. He told the meeting that prescription opioid use, and associated deaths, continue to increase worldwide. “Deaths are nearly always due to ...
Already a member?
Enter your email to keep reading.